PLAIO, a Reykjavík, Iceland-based AI-assisted decision support platform for the pharmaceutical industry, has raised €4.3 million in an oversubscribed funding round. 

Investors 

The round was led by Iðunn, with participation from Frumtak Ventures and Dr. Agon. 

Iðunn is a venture capital fund managed by Kvika Asset Management, based in Reykjavík, Iceland. The fund focuses on investments in life sciences and health technology. 

Iðunn’s investment manager, Pétur Richter, and Andri Sveinsson of Dr. Agon will join PLAIO’s board of directors. 

PLAIO Use of Funds 

The company will use the funds to scale operations in the US and Europe, enhance the AI Coplanner, and strengthen industry partnerships. 

About PLAIO 

PLAIO offers an AI-enhanced sales, operations, and supply chain planning solution specifically designed for the pharmaceutical industry. The platform integrates predictive modeling, AI-driven insights, and user-friendly interfaces to help pharmaceutical companies streamline processes, improve efficiency, and enhance communication. PLAIO's core offering is its AI Coplanner, which allows users to perform scenario analyses, optimize manufacturing workflows, and improve data accuracy for forecasting, procurement, and production scheduling. Over the past year, PLAIO’s client include notable companies such as Covis Pharma, Alvotech, and Camarus. 

Funding Details 

Company: PLAIO ehf 

Amount Raised: €4.3M 

Round: Undisclosed 

Funding Date: August 2024 

Lead Investor: Iðunn 

Additional Investors: Frumtak Ventures, Dr. Agon 

Company Website: https://www.plaio.com/ 

Software Category: Pharma Planning 

Source: https://siliconcanals.com/ai-pharma-planning-platform-plaio-raises-e4-3m/